Investigational drugs for pruritus

  title={Investigational drugs for pruritus},
  author={H. Benecke and T. Lotts and S. St{\"a}nder},
  journal={Expert Opinion on Investigational Drugs},
  pages={1167 - 1179}
  • H. Benecke, T. Lotts, S. Ständer
  • Published 2013
  • Medicine
  • Expert Opinion on Investigational Drugs
  • Introduction: Chronic pruritus (CP), defined as itch lasting for > 6 weeks, is a burdensome symptom of several different diseases, dermatological and systemic, with a high negative impact on the quality of life of patients. Given the manifold aetiologies of CP, therapy is often difficult. In recent years, however, novel substances have been developed for treatment of certain CP entities and identified targets. Areas covered: In this review, the authors present a survey of targets currently… CONTINUE READING
    14 Citations
    [Drug-induced pruritus].
    • 10
    Gabapentin and pregabalin for the treatment of chronic pruritus.
    • 39
    Emerging small-molecule compounds for treatment of atopic dermatitis: a review
    • K. Vávrová
    • Medicine
    • Expert opinion on therapeutic patents
    • 2016
    • 9
    NK-1 Antagonists and Itch.
    • 41
    Recurrent cold‐induced pruritic flush caused by small‐fibre neuropathy in skin grafts
    • 1


    Nalfurafine hydrochloride for the treatment of pruritus
    • S. Inui
    • Medicine
    • Expert opinion on pharmacotherapy
    • 2012
    • 15
    Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
    • 231
    • PDF
    Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T‐cell lymphoma
    • 84
    Pathophysiology of itch and new treatments
    • 76
    • PDF
    Pathophysiology of pruritus in atopic dermatitis: an overview
    • 212
    Treatment of prurigo nodularis with topical capsaicin.
    • 144
    Aprepitant as an antipruritic agent?
    • 114
    Chronic pruritus: a paraneoplastic sign
    • 82
    • PDF